Skip to main content
The Globe and Mail
Get full access to globeandmail.com
Support quality journalism
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
The Globe and Mail
Support quality journalism
Get full access to globeandmail.com
Globe and Mail website displayed on various devices
Just$1.99
per week
for the first 24 weeks

var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){console.log("scroll");var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))}pencilInit(".js-sub-pencil",!1);

Hi Lou,

Was looking at Calian Technologies for some moderate growth and a steady dividend. Wondering what your take on this company is?

Thanks,

Story continues below advertisement

Matt

Hey Matt,

Thanks for the assignment. Calian Technologies Ltd. is a small-cap professional services company that operates in a number of areas including information technology, health care services, contract manufacturing, and systems integration. The stock is thinly traded with average daily volume over the last three months of 4,921 shares. CTY has a healthy history of paying and increasing dividends. The dividend was increased to $0.28 in August and the current yield is 5.6 per cent. The company only has one analyst following their case and the news stream is fairly sparse.

A review of the charts will provide additional insight as to how best to proceed with CTY.

The three-year chart indicates that the shares had a good run but then met resistance in the $21.00 range. The failure to get over the hurdle has brought on some selling that has the stock about to retest support along the 200–day moving average. Worth making note of is the double bottom in the fall of 2011 when the shares caught a bounce off $16.50 and setting the stage for the march to $21.00. Finally the uptrend that started in late December of 2011 was breached in May of 2012, flattening the advance and giving rise to the current retreat.

The six-month chart depicts the selling that surfaced in the middle of September. The MACD generated a buy signal in June at $19.40 and a sell signal in September at $21.00. If you can overcome the fact that CTY is a small-cap company that is thinly traded, has one analyst following its progress and doesn't generate much interest because of scant news, then you might want to look for an entry point once the current selling has abated.

As mentioned many times over the years it is better to confirm the bottom than to anticipate it. Keep an eye on the MACD and see if it generates a buy signal. Currently it appears to be beginning to turn higher.

Story continues below advertisement

Make it a profitable day and happy capitalism!

Have your own question for Lou? Send it to lschizas@globeandmail.com .

Report an error Editorial code of conduct
Tickers mentioned in this story
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies